Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 30, 2019

SELL
$372.08 - $439.57 $36.4 Million - $43 Million
-97,753 Closed
0 $0
Q4 2018

Feb 01, 2019

BUY
$335.82 - $403.04 $3.58 Million - $4.3 Million
10,673 Added 12.26%
97,753 $36.5 Million
Q3 2018

Oct 22, 2018

SELL
$351.14 - $408.51 $6.85 Million - $7.96 Million
-19,495 Reduced 18.29%
87,080 $35.2 Million
Q2 2018

Jul 19, 2018

SELL
$284.6 - $344.99 $12.4 Million - $15 Million
-43,550 Reduced 29.01%
106,575 $36.8 Million
Q1 2018

Apr 13, 2018

BUY
$315.82 - $393.78 $22.8 Million - $28.5 Million
72,320 Added 92.95%
150,125 $51.7 Million
Q4 2017

Feb 22, 2018

BUY
$358.63 - $469.95 $27.9 Million - $36.6 Million
77,805
77,805 $29.3 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $122B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Adamcapital Gestao De Recursos Ltda. Portfolio

Follow Adamcapital Gestao De Recursos Ltda. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adamcapital Gestao De Recursos Ltda., based on Form 13F filings with the SEC.

News

Stay updated on Adamcapital Gestao De Recursos Ltda. with notifications on news.